Safran (ENXTPA:SAF) is back in focus after Electra.aero confirmed a life of program production agreement for TG600 turbogenerators to power its EL9 Ultra Short hybrid electric aircraft.
See our latest analysis for Safran.
The Electra.aero agreement comes as Safran’s share price, now at €329.8, shows mixed short term momentum with a 22.15% 90 day share price return but a more moderate 7.36% year to date share price return. The 1 year, 3 year and 5 year total shareholder returns of 20.18%, 126.44% and 213.47% respectively point to strong longer term compounding.
If this kind of aerospace electrification story interests you, it could be worth broadening your search to other potential beneficiaries in related supply chains by checking out 34 robotics and automation stocks
Safran now trades at a mid single digit discount to both analyst targets and an intrinsic value estimate after a strong multi year run. Is this a genuine margin of safety, or a market warning about risks ahead?
Safran’s most followed narrative points to a fair value of €343.56 versus the last close at €329.8, framing a modest implied discount and putting execution front and center.
The recent acquisition of Collins' actuation and flight control assets, along with other targeted acquisitions and strategic partnerships, will broaden Safran's mission-critical offering, drive cost synergies through 2028, and further diversify revenue streams, likely resulting in higher EBIT margins and more stable earnings.
Want to see what kind of revenue build, margin profile, and valuation multiple have to line up for that outcome? The narrative leans heavily on future earnings power and a richer P/E than the wider aerospace and defense sector. Curious which assumptions really carry the fair value here? The full breakdown joins the dots.
Result: Fair Value of €343.56 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, supply chain setbacks in engine programs and pressure from large customers such as Airbus and Boeing could still squeeze Safran’s margins and weaken the current valuation case.
Find out about the key risks to this Safran narrative.
With Safran’s story showing both pressure points and brighter spots, it makes sense to check the data yourself and decide where you stand. To weigh the full mix of potential upsides and concerns in one place, review the 4 key rewards and 2 important warning signs
Safran might fit your thesis today, but some of the best opportunities often sit just outside your current watchlist, so do not leave them unchecked.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com